Editor Details
Liwu Fu
Director, Department of Experimental Research (Cancer Institute), Cancer Center, Sun Yat-sen University, Guangzhou, China
Fu holds an M.D. from Guangdong Medical and Pharmaceutical College and pursued postgraduate studies, including a Ph.D. in Medicine from Sun Yat-sen University of Medical Sciences.He has held various positions at the Cancer Institute, Cancer Center, Sun Yat-sen University, Guangzhou, China, including Professor, Director, and Head of the Department of Anticancer Drug. Fu is actively involved in numerous professional societies and serves in leadership roles. He is an editorial board member and reviewer for several prestigious scientific journals, contributing significantly to the peer-review process and scientific discourse. His research interests primarily focus on cancer pharmacology, chemotherapy, multidrug resistance, and personalized chemotherapy. Key areas of investigation include cancer stem cells, tyrosine kinase inhibitors, ABC transporters, and exosomes in cancer biology. Fu has secured substantial peer-reviewed grants as the Principal Investigator, reflecting the recognition and support for his research endeavors. His publication record is prolific, with numerous peer-reviewed journal articles that have significantly advanced our understanding of cancer biology and treatment modalities. Notable Contributions: Fu continues to explore novel therapeutic strategies, including the development of targeted therapies and the identification of biomarkers for treatment response. His multidisciplinary approach integrates basic science discoveries with clinical applications, aiming to improve cancer treatment outcomes and patient care. In summary, Liwu Fu's comprehensive expertise, dedication to research, and impactful contributions make him a prominent figure in the field of cancer biology and therapy, with a profound influence on advancing scientific knowledge and clinical practice.
